Method of inducing platelet antiaggregation activity

Details Method of inducing platelet antiaggregation activity Method of inducing platelet antiaggregation activity

1978-07-24

1980-09-09

Fagelson, Anna P.

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Fungus, except allergen, or component thereof or substance...

A61K 3140

Patent

active

042218055

ABSTRACT:
Compositions useful for platelet antiaggregation activity are described, which contain as the active ingredient N-(2-chlorobenzyl)-pyrrolidine or a pharmacologically compatible salt thereof with an organic or an inorganic acid, and at least one pharmaceutically acceptable carrier or excipient. The compositions in the form of an aqueous solution are administered orally in the dose of 2-8 mgs/kg, preferably 3 mgs/kg body weight twice a day. The compositions may also be administered intravenously or endoperitoneally. The compositions may be administered in the form of capsules, ampoules or in the form of oily suspensions, solutions or emulsions.

REFERENCES:
Chem. Abst. vol. 60, No. 499b pp. 496-500, 1963, Erdtman et al.
Chem. Abst., vol. 79, No. 133,415s, p. 70, 1973, McDonald et al.

Affiliated with

Also associated with

Rating

Method of inducing platelet antiaggregation activity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of inducing platelet antiaggregation activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of inducing platelet antiaggregation activity will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2224418